TRANG LIEU: Open Payments
NPI 1922708916 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$895 in 7 payments from 6 companies in 2025. Trend: 2023 $103 · 2024 $312 · 2025 $895
Food & beverage: $895
| Company | Payments | Amount |
|---|---|---|
| Tris Pharma Inc | 2 | $250 |
| Janssen Pharmaceuticals, Inc | 1 | $150 |
| Alkermes, Inc. | 1 | $128 |
| Neurocrine BioSciences, Inc. | 1 | $125 |
| Otsuka America Pharmaceutical, Inc. | 1 | $124 |
| Vanda Pharmaceuticals Inc. | 1 | $119 |
Products named: Dyanavel XR, INVEGA, ARISTADA, INGREZZA, ABILIFY MAINTENA, FANAPT.
Industry payments across TX — which companies pay providers there.
